IS SERUM FIBROBLAST GROWTH FACTOR 21 ASSOCIATED WITH THE SEVERITY OR PRESENCE OF CORONARY ARTERY DISEASE?

Date
2022
Author
GÜNVER, Mehmet Güven
Nar, Rukiye
Kilic, Oguz
Ozen, Mehmet Furkan
Sevgican, Cihan Ilyas
Nar, Gokay
Sanlialp, Sara Cetin
Metadata
Show full item record
Abstract
Background: Recent studies have shown that increased circulating concentrations of fibroblast growth factor 21 (FGF21) are associated with obesity, metabolic disorder, and atherosclerosis. However the relationship between FGF21 and coronary artery disease (CAD) is controversial This study was planned to investigate the role of FGF21 in CAD development and CAD severity.
URI
http://hdl.handle.net/20.500.12627/184448
https://avesis.istanbul.edu.tr/api/publication/bc01a8c8-80a6-4f58-abbc-fce2f4e824be/file
https://doi.org/10.5937/jomb0-30191
Collections